Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
Cytarabine (Ara-C) and Daunorubicin (Dnr) forms the backbone of acute myeloid leukemia (AML) therapy. Drug resistance and toxic side effects pose a major threat to treatment success and hence alternate less toxic therapies are warranted. NF-E2 related factor-2 (Nrf2), a master regulator of antioxida...
Saved in:
Main Authors: | Sreeja Karathedath, Bharathi M Rajamani, Syed Mohammed Musheer Aalam, Ajay Abraham, Savitha Varatharajan, Partha Krishnamurthy, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0177227&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NRF2 and Age-Dependent RPE Degeneration
by: Chen, Yan, et al.
Published: (2012) -
Effect of new water-soluble phenolic antioxidants on the activity of Nrf2-driven enzymes, glutathione system, and Nrf2 translocation into the nucleus
by: E. B. Menshchikova, et al.
Published: (2020-12-01) -
Nrf2 Activation, an Innovative Therapeutic Alternative in Cerebral Ischemia
by: Silva-Islas, Carlos, et al.
Published: (2012) -
NRF2 regulates lipid droplet dynamics to prevent lipotoxicity
by: Christopher T. Prevost, et al.
Published: (2025-07-01) -
Decoding the NRF2–NOTCH Crosstalk in Lung Cancer—An Update
by: Angelo Sparaneo, et al.
Published: (2025-05-01)